A product financing arrangement is accounted for as a secured borrowing, not a sale. Under ASC 470-40, when a company transfers inventory to another party and commits to repurchase it at a price covering the original transfer amount plus the other party’s carrying and financing costs, the cash received is a liability, the inventory stays on the balance sheet, and the financing return accrues as interest expense over the life of the deal.1Financial Accounting Standards Board. Summary of Statement No. 49 No revenue, no cost of goods sold, no gain or loss on transfer.
The rest of the work is confirming the arrangement actually falls under ASC 470-40, booking the entries correctly, keeping the cash flow statement honest, and disclosing enough for a reader to understand what the company has done.
Confirm the Arrangement Qualifies as a Financing
Before anything hits the ledger, run the ASC 470-40 test. Two conditions have to hold.
The sponsor must be committed to repurchase the product, a substantially identical product, or processed goods that incorporate the original product. A vague option or right of first refusal does not qualify on its own, but a binding forward commitment or a call option priced to make exercise virtually certain does.
The repurchase price must insulate the other party from the risks of ownership. If the formula is set so the other party cannot lose money from market declines, obsolescence, or spoilage, that party is functioning as a lender. The price typically works out to the original transfer price plus storage, insurance, and a financing return.1Financial Accounting Standards Board. Summary of Statement No. 49
When both conditions are met, the standard requires financing treatment with no discretion. The legal paperwork can say “sale” all it wants.
ASC 606 reaches the same place from a different direction. Under ASC 606-10-55-70, a seller that retains a forward repurchase obligation or a call option has not transferred control, so revenue is not recognized. If the repurchase price equals or exceeds the original selling price, the transaction is a financing arrangement: the seller keeps the asset, records a financial liability for the cash received, and recognizes the difference between the cash received and the repurchase price as interest expense (and, where applicable, as processing or holding costs) over the life of the agreement.2Financial Accounting Standards Board. Revenue from Contracts with Customers (Topic 606) – Section A
Record the Entries
At Inception
The cash received from the other party is credited to a financing obligation. The inventory stays at its existing carrying value; many companies reclassify it to a line like “inventory pledged under financing arrangement” so a reader can see what is encumbered, but it is not derecognized. No revenue appears, and no cost of goods sold is recorded.
A simple illustration: a sponsor transfers $1,000,000 of inventory and receives $980,000 in cash. The sponsor debits cash $980,000 and credits a financing obligation $980,000. The inventory remains on the balance sheet at its carrying value.
During the Holding Period
Interest expense accrues over time to reflect the financing return owed to the other party. If the arrangement also requires the sponsor to reimburse storage or insurance, those costs are recognized as expenses when incurred. The liability balance grows by the accrued but unpaid interest.
The inventory remains subject to normal lower-of-cost-or-net-realizable-value testing. The sponsor still bears the economic risk of a decline in value, so impairment analysis works the way it would for any other inventory on hand.
At Repurchase
At the repurchase date, the sponsor pays the agreed price covering principal, accrued financing costs, and any holding costs. The financing obligation is debited to zero, the final interest expense is recorded, and cash is credited. The inventory remains on the books because it was there all along; it is now unencumbered and available for ordinary sale.
Classify the Cash Flows Correctly
The cash flow statement has to match the financing substance. The cash received at inception is a financing inflow, not an operating inflow. Classifying it as operating would inflate operating cash flow, which lenders and analysts watch closely, and it is one of the more common errors regulators catch.
At repurchase, the principal portion of the payment is a financing outflow. The interest portion is typically presented as an operating outflow, consistent with interest on other debt.
Disclose Enough for a Reader to Understand It
Footnotes should let a reader see what the arrangement is, what it costs, and how much of it is outstanding. At a minimum:
- A description of the arrangement, its purpose, and the relationship between the sponsor and the other party, including whether the other party is a related entity or a special purpose entity set up for the transaction.
- The repurchase date or window, the formula used to calculate the repurchase price, and the effective interest rate or financing return embedded in the deal.
- The carrying value of inventory pledged or held under product financing arrangements at the balance sheet date.
- The total financing liability, split between current and non-current.
- An explicit statement that the transaction is accounted for as a financing arrangement rather than a sale.
SEC registrants have an additional layer. Any obligations under product financing arrangements that could materially affect liquidity, capital resources, or results of operations must be discussed in Management’s Discussion and Analysis under the off-balance-sheet disclosure rules in Regulation S-K.
Check Whether You Have to Consolidate
If the other party is a special purpose entity created at the sponsor’s direction, the sponsor has to evaluate consolidation under the variable interest entity rules in ASC 810. The sponsor is the primary beneficiary, and must consolidate, if it absorbs the majority of the entity’s expected losses or receives the majority of its expected residual returns.
Consolidation is often the expected outcome in these arrangements because the sponsor controls the entity’s activities and takes all the economic risk through the repurchase commitment. The result on the consolidated statements is the same as financing treatment at the parent level: inventory stays on the balance sheet, the external borrowing shows as debt, and no intercompany revenue is recognized.
When Sale Treatment Survives
Sale treatment is rare in a product financing arrangement because the structure is built to guarantee the other party’s return. For a sale to be recognized, the other party has to assume real ownership risk: exposure to market price declines, obsolescence, and demand uncertainty, with no guaranteed return from the sponsor.
If an arrangement actually meets those conditions, the sponsor recognizes revenue on transfer, removes the inventory, and books cost of goods sold. Any later repurchase is a new inventory purchase at the then-current price. In practice, an arrangement that truly transfers all the risks and rewards to the buyer is not a product financing arrangement at all; it is an ordinary sale with an unrelated repurchase.
One ASC 606 wrinkle is worth noting: if a call option on previously transferred product lapses unexercised, the sponsor derecognizes the liability and recognizes revenue at that point.2Financial Accounting Standards Board. Revenue from Contracts with Customers (Topic 606) – Section A
Why Getting It Right Matters
Misclassifying a product financing arrangement as a sale overstates revenue, understates liabilities, and inflates operating cash flow at the same time. That triple distortion is difficult to defend as an honest mistake and is exactly the pattern SEC enforcement looks for. Revenue recognition has consistently sat at the top of the SEC’s enforcement priorities, and roughly a third of enforcement actions in fiscal year 2022 alleged improper revenue recognition. Companies that have restated in this area have typically faced audit committee investigations and multi-period restatements.
When the other party has a guaranteed return and the sponsor keeps the risk, the accounting answer is financing treatment. Searching for a technical argument to get to sale treatment is not worth the restatement exposure.